Medically Unexplained Symptoms

Introduction

Medically unexplained symptoms (MUS), increasingly termed persistent physical symptoms (PPS), are physical symptoms that persist despite appropriate clinical assessment and investigation, and which are not adequately explained by an identifiable structural or biochemical disease process. They are extremely common: estimates suggest that a substantial minority of all primary care consultations, and up to half of new presentations in some specialist clinics, fall into this category.¹

This is a high-yield and easily mishandled topic. The exam-relevant skill is not remembering a differential list, but demonstrating a management approach that avoids two classic errors: dismissing the symptoms as psychological or imaginary, and pursuing escalating, low-yield investigation in search of a diagnosis that repeated normal results make increasingly unlikely to exist.

Understanding the mechanism

MUS is best understood through a biopsychosocial model rather than a dichotomy between 'physical' and 'psychological' causes. A leading explanatory framework is central sensitisation: persistent pain or other symptoms driven by altered processing in the central nervous system, where pain and symptom pathways become amplified and more easily triggered, independent of ongoing tissue damage.²

• Predisposing factors: genetic vulnerability, adverse childhood experiences, prior chronic illness, and personality traits associated with high symptom vigilance
• Precipitating factors: an infection, injury or life stressor that triggers the initial symptom episode, after which the underlying trigger resolves but the symptom pattern persists
• Perpetuating factors: unhelpful illness beliefs, fear-avoidance of activity, deconditioning, ongoing stress, and iatrogenic reinforcement through repeated investigation and inconsistent messaging from different clinicians

This framework explains overlap between recognised functional syndromes - irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, non-cardiac chest pain, functional neurological disorder - which frequently coexist in the same patient and share management principles even though they are labelled by body system.

Patients frequently meet criteria for more than one of these simultaneously, and treating them as entirely separate problems - referring separately to gastroenterology, rheumatology and cardiology for what may be a shared underlying process - can fragment care and multiply the very repeated investigation that perpetuates symptoms.

Clinical assessment

A careful history and examination remain essential, both to identify red flags requiring further investigation and to build the foundation for a validating, positive explanation later.

• Full symptom history including onset, triggers, pattern, and impact on function, work and relationships
• Screen explicitly for depression and anxiety - highly prevalent alongside MUS and often under-recognised, though their presence does not mean the physical symptoms are 'caused by' them in a simplistic sense
• Ask about health beliefs and previous experiences of investigation - what does the patient think is happening, and what are they most afraid of?
• Review the history of prior consultations and investigations to avoid unnecessary repeat testing and to understand what reassurance has and has not worked before
• Assess functional impact concretely - sleep, work attendance, activity levels - since this guides a graded rehabilitation plan more usefully than symptom severity alone

Investigation strategy

Investigate proportionately to red flags and clinical findings, then resist the urge to keep testing 'just in case'. Over-investigation is not a neutral act of reassurance - it can reinforce the belief that something serious has been missed, increase health anxiety, and delay engagement with effective management.

Giving a positive explanation

The single most examinable communication skill in this topic is explaining MUS constructively: acknowledging the symptoms as real, giving a coherent mechanism, and avoiding language that implies the patient is imagining or fabricating them.

• Validate first: "I can see this pain is real and it's having a big impact on your life"
• Explain a mechanism in plain terms: for example, "Your nervous system has become more sensitive to signals from your body, a bit like a car alarm that's become too easily triggered - it goes off even for small bumps, not just serious ones"
• Reframe the goal: from finding and eliminating a cause to managing symptoms and improving function, which is often achievable even when the underlying mechanism cannot be fully 'cured'
• Avoid dismissive language: "there's nothing wrong with you", "it's just stress", or "it's all in your head" damage the therapeutic relationship and increase doctor-shopping

Management

Management is multimodal and works best when consistent across whoever the patient sees, which is one of the strongest arguments for continuity of care in this group of patients.³

• Graded activity/exercise: a structured, incremental increase in activity, paced to avoid symptom flare-ups, counters the deconditioning and fear-avoidance cycle that perpetuates many functional syndromes
• Cognitive behavioural therapy (CBT)-based approaches: address unhelpful illness beliefs, catastrophising and avoidance behaviour, with good evidence across several functional syndromes
• Treat comorbid depression and anxiety actively where present - this often improves physical symptom burden even when the physical symptoms are not 'caused by' the mood disorder
• Low-dose tricyclic antidepressants (e.g. amitriptyline) are used for their analgesic, sleep-modulating effect in some functional pain syndromes, independent of any antidepressant effect - a frequently examined point of prescribing rationale
• Regular, scheduled review rather than symptom-triggered emergency contact, which reduces reinforcement of the sick role and gives a predictable structure for both patient and clinician
• A single, consistent clinician where possible, to avoid conflicting explanations and repeated re-investigation by different doctors unaware of the prior work-up

The clinician-patient relationship

Patients with persistent physical symptoms frequently describe feeling disbelieved, dismissed, or passed between specialists without anyone taking overall responsibility - and this experience itself can worsen outcomes by increasing distress and driving further help-seeking in search of validation. Building and maintaining trust is not a soft add-on to management here; it is close to the core intervention.

• Acknowledge uncertainty honestly where it exists, rather than overstating confidence in a mechanism that is still partly understood
• Avoid framing the consultation as a battle over whether the symptoms are 'real'
• Set expectations early about what investigation can and cannot achieve, so a normal result is not experienced as a dead end
• Involve the patient explicitly in decisions about further testing versus a management-focused approach, rather than presenting it as the clinician's decision alone
• Recognise and name your own frustration if it arises, since it can leak into tone and language in ways that damage the relationship without the clinician necessarily intending it

Common pitfalls

• Repeated, escalating investigation in search of a diagnosis, without a clear rationale for each new test
• Dismissive labelling ('heart-sink patient', 'it's psychological') that damages rapport and engagement
• Inconsistent messages from different clinicians, particularly across primary and secondary care, undermining a coherent explanation
• Missing a genuine new diagnosis by anchoring on the existing MUS label and failing to reassess new or changed symptoms on their own merits
• Over-medicalising by referring reflexively to multiple specialists rather than coordinating care through a single clinician

Red flags

Related but distinct diagnoses

Several psychiatric diagnoses overlap with persistent physical symptoms but are conceptually distinct, and confusing them - particularly implying deliberate fabrication where none exists - causes real harm to the therapeutic relationship.

Prognosis

Outcomes vary widely by syndrome and duration, but a substantial proportion of patients improve with a consistent, validating, biopsychosocial approach, particularly when engaged early before chronic illness behaviour and significant functional impairment become entrenched. Longer duration of symptoms, greater functional impairment at presentation, and untreated comorbid depression or anxiety are all associated with a poorer outcome.

The realistic goal for many patients is not complete symptom resolution but meaningful improvement in function and quality of life, achieved through active self-management rather than a search for a definitive cure - a framing worth using explicitly when agreeing a plan.

It is also worth remembering that this is a genuinely common presentation across every specialty, not a niche interest confined to primary care or psychiatry - a cardiologist managing non-cardiac chest pain, a gastroenterologist managing irritable bowel syndrome, and a neurologist managing functional neurological disorder are all applying the same underlying principles described here, which is part of why this topic is tested so consistently across a wide range of clinical scenarios.